ICU Medical (ICUI)
(Delayed Data from NSDQ)
$131.71 USD
-1.31 (-0.98%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $131.73 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ICUI 131.71 -1.31(-0.98%)
Will ICUI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ICUI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICUI
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
ICUI: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
Other News for ICUI
Technical picture remains unchanged for ICUI after it falls 0.98% on September 19
20 Day Moving Average Support appears for ICUI after 3.04% move
ICUI forms 20 Day Moving Average Support on September 17
The technical outlook for ICUI is unchanged after it falls 1.37% on September 16
Is ICUI likely to continue higher? 180 Bullish Setup shows up after gaining 1.37%